US House Co-signs Banking For Hemp Industry
Using Cannabinoids In Supplements Remains Unlawful Under FDA Regulations
Executive Summary
House passes “SAFE Banking” Act sponsored by Rep. Ed Perlmutter to allow cannabis- and hemp-related businesses in states with some form of legalized marijuana to access financial services by creating protections for those institutions. Sen. Jeff Merkley introduced the same legislation in March.
You may also be interested in...
Science Board Meeting Could Launch US Toward Lawful Hemp Use, Or Extend Market Limbo
Questions FDA is asking advisors and the public could generate answers propelling it toward determining whether hemp use in supplements should be lawful with a waiver of its prohibition against using ingredients studied or approved as a drug; or, the answers could stop the FDA in its feet.
US Cannabis Legalization Cultivated By House Has Thorny Forecast For Harvest In Senate
Absence of hemp provisions in House bill could be a problem with Senate Democrats, who have drafted legislation not only on producing, marketing and possessing marijuana but also using in supplements ingredients classified as hemp. Still, Senate passage of cannabis legalization is unlikely.
After US FDA Objects To CBD Safety As NDIs, Supplement Industry Responds, What Else Is New?
Rejection of two firms’ proposals for using hemp-derived CBD in supplement isn’t stirring US businesses selling CBD supplements to pull products from market. For one firm that filed an unsuccessful NDI notification for full-spectrum hemp extract CBD, FDA rejection was agenda item with numerous other business, regulatory and legislative developments in its latest quarter.